Skip to main content
Equibles

Scott Garland

Board Member

Alx Oncology Holdings Inc (ALXO)

Chairman

Alx Oncology Holdings Inc (ALXO)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alx Oncology Holdings Inc publishes a filing, an earnings call transcript or a press release.

Get ALXO alerts

About Scott Garland

Scott Garland is recorded as Chairman at Alx Oncology Holdings Inc (ALXO) since June 29, 2026 and Board Member at Alx Oncology Holdings Inc (ALXO). The newest filing on record that lists Scott Garland as Board Member at Alx Oncology Holdings Inc (ALXO) is dated April 20, 2026. Alx Oncology Holdings Inc reported in an 8-K filed June 30, 2026 that Scott Garland was appointed Chairman of the Board, effective June 29, 2026. Alx Oncology Holdings Inc reported in an 8-K filed November 29, 2022 that Scott Garland was appointed Board of Directors, effective November 28, 2022. Alx Oncology Holdings Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alx Oncology Holdings Inc includes Jason Lettmann (CEO and Board Member), Harish Shantharam (CFO), Michael Listgarten (General Counsel) and 7 others.

“In connection with Dr. Goodman’s resignation, the Board appointed Scott Garland, an independent director of the Company, to serve as Chairman of the Board, effective as of June 29, 2026.”
Alx Oncology Holdings Inc Form 8-K, filed June 30, 2026 · Read the filing
“Effective as of November 28, 2022, the Board of Directors of ALX Oncology Holdings Inc. (the "Company") appointed Scott Garland to its Board of Directors and increased the size of its Board of Directors from seven to eight directors in connection with his appointment.”
Alx Oncology Holdings Inc Form 8-K, filed November 29, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Alx Oncology Holdings Inc

Recent activity